I lost my home in the Pacific Palisades fire. Although wildfires have become a part of modern life, you can take steps to ...

The following story is part two of a two-part series examining the devastating impact of black lung disease on the lives of ...

Lung Cancer is the most deadly cancer in the U.S. About 70% of people who develop lung cancer pass away within five years, according to the CDC.

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

Indiana ranks worst in the U.S. for lung health due to high smoking rates and poor air quality, while Colorado and Hawaii ...

Silent Lungs, Hidden Clues: What Chest CTs Reveal About IgG4-Related Disease —Investigators in Argentina recently examined a small subset of patients with immunoglobulin G4-related disease (IgG4 ...

The American Lung Association and the Iowa Department of Health and Human Services (Iowa HHS) congratulate the winners of the 2025 Iowa Radon Poster and Video Contest. The annual contest raises ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first. Insilico Medicine, the biotech company ...

Lung biopsy shows Landfried has rare disease Once Landfried's condition stabilized and she was no longer leaking air from her lungs, she returned to Children's Hospital in November for a lung biopsy.

The Pulmonary Fibrosis Trust said the "rare" disease has an average life expectancy of between three-to five years after diagnosis and in the majority of cases, the cause was unknown.

A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life ...

Details of the poster presentations appear below. The posters will be available on the aTyr website once presented. Title: Real-World Treatment Patterns Among Pulmonary Sarcoidosis Patients with ...